Selective 5-hydroxytryptamine antagonism: A role in irritable bowel syndrome and functional dyspepsia?

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 595-599

  Maxton, D G ^a   Morris, J ^a   Whorwell, P J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ONDANSETRON; PLACEBO; SEROTONIN RECEPTOR;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FEMALE; FLATULENCE; HEARTBURN; HUMAN; INTESTINE MOTILITY; IRRITABLE COLON; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM;

EID: 0030036160     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.30172000.x     Document Type: Article

References (17)

1. 3 receptors. Med Res Rev 1990; 10: 441-75.
2. Costall B, Naylor RJ. 5-Hydroxy-tryptamine: new receptors and novel drugs for gastrointestinal motor disorders. Scand J Gastroenterol 1990; 25: 769-87.
3. Talley NJ. 5-HT agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 1992; 6: 273-89.
4. Farthing MJG. 5-Hydroxy-tryptamine and 5-hydroxy-tryptamine-3 receptor antagonists. Scand J Gastroenterol 1991; 26 (Suppl. 188): 92-100.
5. 3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 1990; 35: 477-80.
6. 3) receptor antagonist ondansetron (GR38032F) in diarrhoea predominant irritable bowel syndrome (IBS). Gastroenterology 1990; 98 (Suppl. 92): A394.
7. 3 receptor antagonist in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 175-80.
8. Read NW. Irritable bowel syndrome (IBS). Definition and pathophysiology. Scand J Gastroenterol 1987; 22 (Suppl. 1130): 7-13.
9. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 37-40.
10. Thompson WG, Doterall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guideline for the diagnosis (WorkingTeam Report). Gastroenterol Int 1989; 2 (2): 92-5.
11. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand 1983; 67: 361-70.
12. Kenward MG, Jones B. A log-linear model for binary cross-over data. Appl Statist 1987; 36: 192-204.
13. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 1972; 28: 577-84.
14. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232-41.
15. Maxton DG, Morris J, Whorwell PJ. Improving clinical trials in irritable bowel syndrome: some practical aspects. Eur J Gastroenterol Hepatol 1992; 4: 337-41.
16. 3 receptor antagonist) on gastric emptying of a solid meal in normal subjects. Gut 1988; 29: 1249-52.
17. Marsden CA. The pharmacology of new anxiolytics acting on 5-HT neurones. Postgrad Med J 1990; 66 (Suppl. 2): 51-6.